BEVERLY MASER: Open Payments
NPI 1487932232 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 21 payments from 12 companies in 2025. Trend: 2023 $55 · 2024 $321 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 4 | $95 |
| ViiV Healthcare Company | 3 | $82 |
| Aimmune Therapeutics, Inc. | 2 | $62 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Gilead Sciences, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Theratechnologies Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
Products named: Arikayce, VOWST, DOVATO, PIFELTRO, RUKOBIA, HYQVIA, EGRIFTA, NUZYRA.
Industry payments across DE — which companies pay providers there.
